Edwards software may reduce hypotension severity, study says
Edwards Lifesciences today announced study results that support the use of its Acumen HPI software.
Stay updated with breaking news from Thomas Scheeren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Edwards Lifesciences today announced study results that support the use of its Acumen HPI software.
Edwards Lifesciences (NYSE:EW) today announced results from a registry demonstrating the effect of software on reducing hypotension.
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference News provided by Share this article Share this article IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and share its financial guidance today during its annual investor conference. Highlights Presenting long-term strategic initiatives and growth outlook Projecting 2021 global sales of $4.9-5.3 billion; underlying growth in the mid-teens Projecting 2021 TAVR sales of $3.2-...